Similar articles for PMID: 29707145

Year	Number of Results
2012	1
2013	2
2014	1
2015	6
2016	16
2017	9
2018	3
2019	6
2020	2
2021	7
2022	1
2023	1
2024	0

1

Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor.

Vandeputte C, Kehagias P, El Housni H, Ameye L, Laes JF, Desmedt C, Sotiriou C, Deleporte A, Puleo F, Geboes K, Delaunoit T, Demolin G, Peeters M, D'Hondt L, Janssens J, Carrasco J, Marechal R, Galdon MG, Heimann P, Paesmans M, Flamen P, Hendlisz A. Vandeputte C, et al. Oncotarget. 2018 Apr 3;9(25):17756-17769. doi: 10.18632/oncotarget.24879. eCollection 2018 Apr 3. Oncotarget. 2018. PMID: 29707145 Free PMC article.

2

Quantification of mutant alleles in circulating tumor DNA can predict survival in lung cancer.

Yang X, Zhuo M, Ye X, Bai H, Wang Z, Sun Y, Zhao J, An T, Duan J, Wu M, Wang J. Yang X, et al. Oncotarget. 2016 Apr 12;7(15):20810-24. doi: 10.18632/oncotarget.8021. Oncotarget. 2016. PMID: 26989078 Free PMC article.

3

Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma.

Gray ES, Rizos H, Reid AL, Boyd SC, Pereira MR, Lo J, Tembe V, Freeman J, Lee JH, Scolyer RA, Siew K, Lomma C, Cooper A, Khattak MA, Meniawy TM, Long GV, Carlino MS, Millward M, Ziman M. Gray ES, et al. Oncotarget. 2015 Dec 8;6(39):42008-18. doi: 10.18632/oncotarget.5788. Oncotarget. 2015. PMID: 26524482 Free PMC article.

4

Proof of concept: prognostic value of the plasmatic concentration of circulating cell free DNA in desmoid tumors using ddPCR.

Macagno N, Fina F, Penel N, Bouvier C, Nanni I, Duffaud F, Rouah R, Lacarelle B, Ouafik L, Bonvalot S, Salas S. Macagno N, et al. Oncotarget. 2018 Apr 6;9(26):18296-18308. doi: 10.18632/oncotarget.24817. eCollection 2018 Apr 6. Oncotarget. 2018. PMID: 29719606 Free PMC article.

5

Circulating Tumor DNA Dynamics and Treatment Outcome of Regorafenib in Metastatic Colorectal Cancer.

Lee DW, Lim Y, Kim HP, Kim SY, Roh H, Kang JK, Lee KH, Kim MJ, Ryoo SB, Park JW, Jeong SY, Park KJ, Kang GH, Han SW, Kim TY. Lee DW, et al. Cancer Res Treat. 2023 Jul;55(3):927-938. doi: 10.4143/crt.2023.268. Epub 2023 Mar 7. Cancer Res Treat. 2023. PMID: 36915247 Free PMC article.

6

Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patients.

Cheng H, Liu C, Jiang J, Luo G, Lu Y, Jin K, Guo M, Zhang Z, Xu J, Liu L, Ni Q, Yu X. Cheng H, et al. Int J Cancer. 2017 May 15;140(10):2344-2350. doi: 10.1002/ijc.30650. Epub 2017 Mar 9. Int J Cancer. 2017. PMID: 28205231 Free article.

7

Plasma Circulating Tumor DNA in Pancreatic Cancer Patients Is a Prognostic Marker.

Pietrasz D, Pécuchet N, Garlan F, Didelot A, Dubreuil O, Doat S, Imbert-Bismut F, Karoui M, Vaillant JC, Taly V, Laurent-Puig P, Bachet JB. Pietrasz D, et al. Clin Cancer Res. 2017 Jan 1;23(1):116-123. doi: 10.1158/1078-0432.CCR-16-0806. Epub 2016 Dec 19. Clin Cancer Res. 2017. PMID: 27993964

8

Detection of circulating tumor DNA in patients of operative colorectal and gastric cancers.

Suzuki T, Suzuki T, Yoshimura Y, Yahata M, Yew PY, Nakamura T, Nakamura Y, Park JH, Matsuo R. Suzuki T, et al. Oncotarget. 2020 Aug 25;11(34):3198-3207. doi: 10.18632/oncotarget.27682. eCollection 2020 Aug 25. Oncotarget. 2020. PMID: 32922660 Free PMC article.

9

Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors.

Schreuer M, Meersseman G, Van Den Herrewegen S, Jansen Y, Chevolet I, Bott A, Wilgenhof S, Seremet T, Jacobs B, Buyl R, Maertens G, Neyns B. Schreuer M, et al. J Transl Med. 2016 Apr 19;14:95. doi: 10.1186/s12967-016-0852-6. J Transl Med. 2016. PMID: 27095081 Free PMC article.

10

Total and mutated EGFR quantification in cell-free DNA from non-small cell lung cancer patients detects tumor heterogeneity and presents prognostic value.

Alegre E, Fusco JP, Restituto P, Salas-Benito D, Rodríguez-Ruiz ME, Andueza MP, Pajares MJ, Patiño-García A, Pio R, Lozano MD, Gúrpide A, Lopez-Picazo JM, Gil-Bazo I, Perez-Gracia JL, Gonzalez A. Alegre E, et al. Tumour Biol. 2016 Oct;37(10):13687-13694. doi: 10.1007/s13277-016-5282-9. Epub 2016 Jul 29. Tumour Biol. 2016. PMID: 27473086

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

51 results

Results by year